OncoTherapy Science, Inc. (TYO:4564)
15.00
0.00 (0.00%)
Nov 18, 2026, 10:29 AM JST
OncoTherapy Science Market Cap
OncoTherapy Science has a market cap or net worth of 6.12 billion as of November 17, 2026. It is the 31,254th most valuable company in the world and the 2,808th biggest in Japan. Its market cap has decreased by 21.38% in one year.
Market Cap
6.12B
Enterprise Value
4.04B
Revenue
712.00M
Global Rank
Country Rank
#2,808 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since June 29, 2007, OncoTherapy Science's market cap has decreased from 13.84B to 6.12B, a decrease of -55.76%. That is a compound annual growth rate of -4.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 6.12B | -10.90% |
| Dec 30, 2025 | 6.87B | 1.20% |
| Dec 30, 2024 | 6.79B | 35.66% |
| Dec 29, 2023 | 5.01B | -50.03% |
| Dec 30, 2022 | 10.02B | -27.78% |
| Dec 30, 2021 | 13.87B | -31.60% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Carna Biosciences | 7.46B |
| Kidswell Bio | 7.34B |
| ADR Biomedical Holdings | 7.14B |
| StemCell Institute | 6.51B |
| CellSeed | 6.41B |
| TMS Co., Ltd. | 6.35B |
| J-Pharma | 6.34B |
| Nano Holdings | 6.28B |